GenomOncology
PrivateLast Round
Debt
Feb 12, 2021
Total Funding Raised
$2.74M
Company Overview
GenomOncology is a healthtech company that provides a software platform to transform complex clinical and molecular genomic data into actionable intelligence for personalized patient care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Medical AI, Clinical Trials, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenomOncology Comparables
Compare GenomOncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomate Health | 82% | |
| CureMatch | 81% | |
| VieCure | 81% |
GenomOncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 12, 2021 | ||||
| Debt | Apr 27, 2020 | ||||
| Series A | Sep 7, 2016 | ||||
| VC Round | Feb 5, 2014 | ||||
| Seed | Jun 5, 2012 |
Key People
Founding team and executive leadership
GenomOncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KeyBank | Debt |
| JumpStart Ventures | Seed, Series A |
| Zapis Capital Group | Seed |
| TriStar Health Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2021
$637K debt round completed.
- Apr 27, 2020
$604K round led by KeyBank.
GenomOncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenomOncology's valuation, stock price, and market status.
Is GenomOncology a public or private company?
GenomOncology is a private company.
What is the current stock price of GenomOncology?
GenomOncology is a private company with no public stock price. No recent secondary market data is available.
How much is GenomOncology worth (valuation)?
Valuation information for GenomOncology is not publicly available.
Can I buy GenomOncology stock?
GenomOncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenomOncology's last funding round?
GenomOncology's most recent funding round was Debt on February 12, 2021.
Who are the main investors in GenomOncology?
Key investors in GenomOncology include Zapis Capital Group, TriStar Health Partners.
Will GenomOncology IPO soon?
No public IPO plans have been announced for GenomOncology.
How can I track GenomOncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenomOncology's secondary market activity and sign up for updates.